8 September 2016 EMA/348709/2016 Inspections and Human Medicines Pharmacovigilance Division

Draft Agenda – Tenth Stakeholder forum on the Pharmacovigilance legislation 21 September 2016, 09.00-13.00, Room 3/E, European Medicines Agency (EMA) - 30 Churchill Place, Canary Wharf, London, E14 5EU, UK Time

Agenda item

Speakers

08:30 – 09:00 Registration and reimbursement arrangements Session 1 – Pharmacovigilance legislation - what has been achieved and future priorities 09:00 – 09:15

Welcome and Introduction Guido Rasi (EMA)

Session 1 - Co-Chairs: June Raine (PRAC Chair) and Fergus Sweeney (EMA) 09:15 – 10:15



3-year report on Pharmacovigilance

Helen Lee, European Commission

activities •

Scanning the horizon for 2016 – 2018

Peter Arlett, EMA



Activities report from SCOPE (The

June Raine, MHRA, UK

Strengthening Collaboration for Operating Pharmacovigilance in Europe) Joint Action •

Pharmacovigilance Impact – for better

Almath Spooner, HPRA, IE

pharmacovigilance 10:15 – 10:30

Open panel discussion

Session speakers, co-chairs, PCWP representative, HCPWP representative, Representatives from Industry associations

10:30 – 11:00

Coffee break

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Time

Agenda item

Speakers

Session 2 - Regulatory science driving better Pharmacovigilance Session 2 - Co-Chairs: June Raine (PRAC Chair) and Peter Arlett (EMA) 11:00 – 11:30



Turning regulatory science into better

Xavier Kurz, EMA

pharmacovigilance: experience from the PROTECT project •

Harnessing mobile apps and social media for

Philip Tregunno, MHRA, UK

product safety 11:30 – 11:45

Open panel discussion

Session speakers, co-chairs, PCWP representative, HCPWP representative, Representatives from Industry associations

Session 3 - Lifecycle Pharmacovigilance planning for public health Session 3 - Co-Chairs: Almath Spooner (HPRA) and Peter Arlett (EMA) 11:45 – 12:30



Introduction: planning is key to product

Almath Spooner, HPRA, IE

development and safe and effective use of

and Peter Arlett, EMA

products •

Scientific Advice delivers planning during

Spiros Vamvakas, EMA

development •

Epidemiology as an enabler for health

Alison Cave, EMA



Actions from the Risk Minimisation Measures

Jamie Wilkinson, PGEU

Workshop in 2015 12:30 – 12:45

Open panel discussion

Session speakers, co-chairs, PCWP representative, HCPWP representative, Representatives from Industry associations

12:45 – 13:00 Conclusions 13:00

Close of meeting

Draft Agenda – Tenth Stakeholder forum on the Pharmacovigilance legislation EMA/348709/2016

Page 2/2

Agenda - European Medicines Agency - europa.eu

Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

82KB Sizes 12 Downloads 402 Views

Recommend Documents

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

Agenda - European Medicines Agency - Europa EU
Dec 7, 2016 - publication of clinical data (Policy 0070) and revisions to the guidance to industry – Industry Associations Webinar. 9 December 2016, 10:00 to ...

Agenda - European Medicines Agency - Europa EU
Sep 19, 2017 - 14:00-14:05. 2. Data integrity – early signal detection. - data patterns/trends in data ... 16:20-17:00. 5. Inspections of Ligand Binding Assays (in.

Agenda - European Medicines Agency - Europa EU
Nov 7, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone ...... Visualisation of choline metabolism in malignant neoplasms ..... A paediatric investigation plan (PIP) is a dev

Agenda - European Medicines Agency - Europa EU
Jan 23, 2018 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be

Agenda - European Medicines Agency - Europa EU
Oct 24, 2017 - Application of Article 8(2) of the Orphan Regulation ..... propoxy)-phenyl]-methanone, EMA/OD/187/14 Herpes simplex type 1 virus containing.

Agenda - European Medicines Agency - Europa EU
Jun 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... EMA initiatives to support and accelerate early access. 10:00 2.1 ...

Agenda - Patient Registries Workshop - European Medicines Agency
Oct 18, 2016 - Send a question via our website www.ema.europa.eu/contact ... marketing authorisation holder (MAH) to create a new registry based on a ...

Agenda - European Medicines Agency - Europa EU
6 days ago - EMA/OD/103/14 Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment, EMA/OD/175/14 Allogeneic ...

Agenda - European Medicines Agency - Europa EU
o Pilot to test draft model ... Endorsement of Enpr-EMA membership criteria Mark Turner/Irmgard. Eichler ... Endorsement of newly received applications.

Agenda - European Medicines Agency - Europa EU
Jan 23, 2018 - HCP/patient cross-sectional survey and retrospective chart review Post Authorisation. Safety Study to evaluate the effectiveness of the Patient Alert Card for both IV and SC abatacept in a sample of EU countries. Positive Opinion adopt

Agenda - Data anonymisation workshop - European Medicines Agency
Nov 30, 2017 - broader set of data which ensure privacy protection and meet the standards required to maintain ... To understand the legislation impacting clinical data sharing across two jurisdictions, drawing out differences and .... healthcare dat

Agenda - European Medicines Agency - Europa EU
Jan 8, 2018 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. ... EU referral procedures for safety reasons: urgent EU procedures 13. 2.1. ...... clinical data from st

Agenda - European Medicines Agency - Europa EU
Nov 3, 2016 - Scope: 'Optimising the development of ATMPs to meet patient needs' ... the CAT would like to discuss with company representatives in person.